Private vs NHS access — what's the difference?

Why NHS access is the exception, not the rule

Medical cannabis is legal in the UK — but that does not mean it is freely available through the NHS. In practice, NHS prescriptions for cannabis-based medicinal products are restricted to an extremely narrow set of conditions, leaving the majority of eligible patients with one realistic option: private healthcare.

Understanding the difference between NHS and private access is important not just for setting expectations, but for making a confident, informed decision about how to proceed.

NHS vs private — a direct comparison

NHS access is currently restricted to three specific conditions: severe epilepsy, chemotherapy-related nausea, and specific cases of multiple sclerosis. Outside of these, NHS prescriptions for medical cannabis are not available — regardless of how well-documented your condition or how many treatments you have tried.

Private access, by contrast, is available for a significantly wider range of qualifying conditions. Appointment times are faster, treatment options are more flexible, and patients work directly with specialist doctors who have experience prescribing cannabis-based treatment. For most patients in the UK, this is the only practical route to receiving a legal prescription.

Private care is not a workaround — it is the standard

Choosing private access for medical cannabis treatment is not a shortcut or a grey area — it is the established, regulated pathway that the vast majority of UK patients use. It allows you to access treatment sooner, receive personalised care from a qualified specialist, and benefit from ongoing monitoring and support throughout your journey.